News Release: July 29, 2025
Cyclopropanecarboxamide Price, Production, Latest News and Developments in 2025
In 2025, the global market for Cyclopropanecarboxamide has been witnessing a steady transformation, led by shifts in demand dynamics, production capabilities, and global trade flows. The compound, widely used in pharmaceutical intermediates and agrochemical applications, continues to gain prominence. To get more insights on the Cyclopropanecarboxamide price trend and production News, recent data show an evolving pricing structure across major regions.
Cyclopropanecarboxamide Price Trend in Past Five Years and Factors Impacting Price Movements (2019–2024)
Between 2019 and 2024, the price of Cyclopropanecarboxamide fluctuated due to a confluence of factors such as raw material costs, manufacturing disruptions, supply chain challenges, and geopolitical instability. The average global price in 2019 stood at approximately $2,500/MT. Prices remained relatively stable through 2020, with a slight increase to $2,620/MT due to moderate demand from end-user industries.
In 2021, the Cyclopropanecarboxamide price trend turned upward, climbing to $2,870/MT. This increase was driven primarily by constrained supply from key Asian producers, combined with a spike in demand from pharmaceutical manufacturers looking to diversify intermediates during COVID-19 disruptions.
By 2022, prices saw a marked surge to $3,050/MT, underpinned by persistent supply chain bottlenecks and rising energy costs in Europe and Asia. However, this period also witnessed a growth in production capacities in China and India, which acted as a partial price stabilizer.
2023 experienced moderate correction, with prices declining to $2,820/MT due to increased production output, especially from Indian manufacturers, and subdued demand from the agrochemical segment. The recovery in logistics and energy pricing also contributed to easing pressure on producers, which trickled down to the pricing levels.
As of Q4 2024, Cyclopropanecarboxamide prices hovered around $2,780/MT. The trend was impacted by softer global growth projections, cautious restocking by chemical buyers, and a return to normalcy in raw material procurement. However, temporary supply shocks in Southeast Asia due to environmental compliance inspections disrupted the supply chain, causing minor price fluctuations toward year-end.
Key factors influencing the Cyclopropanecarboxamide price trend during this period include volatility in upstream chemicals, evolving regulatory frameworks in major producing nations, technological advancements in synthesis routes, and growing demand from novel drug formulations.
In summary, the five-year period saw a general upward trajectory with intermittent corrections. The volatility highlighted the chemical’s sensitivity to production inputs and external economic pressures.
Cyclopropanecarboxamide Price Trend Quarterly Update in $/MT (2025)
- Q1 2025: $2,820/MT
- Q2 2025: $2,860/MT
- Q3 2025: $2,910/MT
- Q4 2025 (estimated): $2,950/MT
The Cyclopropanecarboxamide price news for 2025 indicates a gradual quarterly increase. In Q1, a stable output kept prices in check. By Q2, slight disruptions in Chinese production due to plant maintenance caused a $40/MT rise. Q3 saw another $50/MT jump as demand in North America rose following increased R&D activities. The forecast for Q4 projects another marginal price climb as inventories in Europe and the US are expected to tighten due to seasonal demand from the pharmaceutical sector.
The Cyclopropanecarboxamide price trend throughout 2025 remains cautiously bullish, reflecting a balance between healthy production levels and steadily rising demand.
Global Cyclopropanecarboxamide Import-Export Business Overview
The global trade scenario for Cyclopropanecarboxamide has evolved significantly, particularly in the last two years. As demand has shifted, countries have responded by adjusting their trade policies, expanding production bases, and targeting new export markets.
Asia-Pacific remains the dominant exporter of Cyclopropanecarboxamide, with China and India accounting for more than 65% of the global Cyclopropanecarboxamide sales volume in 2025. China’s large-scale manufacturing capacity and cost-effective production methods have historically positioned it as the global leader. However, India has made notable strides by ramping up investments in specialty chemicals and API intermediates.
India’s Cyclopropanecarboxamide production capacity surged by over 20% in 2024, and this trend continues in 2025, making it a key supplier to Europe, Latin America, and Southeast Asia. Indian producers are increasingly targeting regulated markets with high-quality output and compliance certifications. The country’s export volume rose from 8,000 MT in 2023 to an estimated 9,500 MT in 2025.
Europe, while being a significant consumer, continues to import substantial quantities due to limited domestic production. Countries like Germany, France, and the Netherlands rely heavily on imports, particularly from India and South Korea. European demand has remained steady in 2025, thanks to strong activity in pharmaceutical innovation and generic drug manufacturing.
In North America, the United States has seen an increase in domestic consumption, driven by innovation in chemical synthesis and API research. However, US domestic production is limited, making it a key importer of Cyclopropanecarboxamide. Import volumes in the US are projected to touch 5,600 MT by end of 2025. US importers have diversified sourcing beyond China, engaging Indian and South Korean suppliers for cost and geopolitical balance.
The Middle East and Africa (MEA) markets are emerging as niche consumers. The demand remains modest, but Cyclopropanecarboxamide sales volume is growing steadily in countries such as the UAE, Saudi Arabia, and South Africa. Imports are driven by pharmaceutical packaging units and formulation labs in the region.
Latin America has also shown moderate interest, particularly in Brazil and Argentina. These markets import mainly from India, leveraging lower costs and shorter shipping durations compared to East Asian suppliers.
While trade routes remain consistent, 2025 saw a few geopolitical events that affected Cyclopropanecarboxamide price news globally. Temporary port shutdowns in Southeast Asia, combined with shipping delays in the Red Sea corridor, caused disruptions in Q2. Nonetheless, diversified shipping logistics and buffer stocks mitigated prolonged market shocks.
In terms of Cyclopropanecarboxamide production, the global output reached an estimated 43,000 MT in 2025. China contributed nearly 18,500 MT, followed by India with 14,200 MT. South Korea, Germany, and Japan contributed smaller volumes but focused on high-purity grades catering to R&D and regulated markets.
On the regulatory front, new compliance protocols introduced in the EU have resulted in importers seeking REACH-compliant material, thereby benefiting Indian exporters with certified products. Meanwhile, in China, the push for green chemistry and sustainable production is leading to investment in cleaner synthesis technologies, expected to yield long-term cost benefits.
Cyclopropanecarboxamide sales volume globally grew by 6.2% in 2025 compared to the previous year. This growth was largely driven by pharmaceuticals, which accounted for nearly 58% of total demand. Agrochemicals made up 25%, and specialty chemicals took the remaining share. The expansion in production capacities, along with stable demand from end-use industries, suggests a positive Cyclopropanecarboxamide price trend going into 2026.
In conclusion, 2025 has been a year of steady growth for the Cyclopropanecarboxamide market. From production ramp-ups and pricing fluctuations to shifting trade dynamics, the compound remains at the core of various critical sectors. The future outlook hinges on regulatory developments, investment in cleaner manufacturing technologies, and diversified sourcing strategies.
For more insights and to request a sample report, please visit: https://datavagyanik.com/reports/cyclopropanecarboxamide-market/
Cyclopropanecarboxamide Production Trends by Geography
The global production of Cyclopropanecarboxamide has undergone substantial shifts over recent years, influenced by advancements in chemical synthesis, evolving trade policies, and expanding end-use sectors. In 2025, production trends are largely defined by regional capabilities, regulatory frameworks, and domestic demand scenarios. The key geographies dominating Cyclopropanecarboxamide production include Asia-Pacific, Europe, North America, and to a smaller extent, Latin America and the Middle East.
Asia-Pacific
Asia-Pacific continues to lead in Cyclopropanecarboxamide production, with China and India emerging as the primary manufacturing hubs. China, benefiting from vast raw material access, cost-effective labor, and advanced synthesis technology, holds the largest production capacity. Its chemical zones in Jiangsu, Zhejiang, and Shandong house some of the most prolific Cyclopropanecarboxamide manufacturers. Despite stricter environmental norms, Chinese companies are rapidly adopting green chemistry techniques to maintain competitiveness.
India has seen robust growth in production output. The country’s policy support for pharmaceutical intermediates and specialty chemicals has fueled investment in production facilities. Indian manufacturers have focused on high-purity Cyclopropanecarboxamide, especially to meet export demand from Europe and North America. Gujarat and Maharashtra are among the key states where production is concentrated.
South Korea and Japan are smaller yet critical producers. Their output is usually targeted toward domestic pharmaceutical applications and high-specification R&D-grade material. South Korean producers also export select volumes to Europe under long-term contracts.
Europe
Europe’s production landscape is more limited due to high production costs and stringent regulatory controls. However, countries like Germany and Switzerland maintain boutique production units that specialize in small-batch, high-purity Cyclopropanecarboxamide. These units primarily serve pharmaceutical innovators and research laboratories.
European producers prioritize quality and compliance, which makes them ideal for regulated markets. However, due to cost disadvantages, large-scale production is not feasible, making Europe a net importer of Cyclopropanecarboxamide despite local capacities.
North America
North America, particularly the United States, has limited domestic production, mostly focused on laboratory-scale or pilot production for pharmaceutical and chemical research. The high cost of production, labor, and raw materials, combined with complex compliance requirements, has led many US companies to depend on imports from Asia.
However, in 2025, North America has seen incremental investments in domestic production capabilities, largely driven by the need to reduce reliance on foreign sources. These are mostly modular production setups using flow chemistry to ensure flexibility and speed to market. Some specialty chemical producers in Texas and California are working on building scale gradually.
Middle East and Africa
The Middle East and Africa region has minimal production of Cyclopropanecarboxamide. The production is restricted to pilot plants or as part of broader chemical synthesis operations. However, the UAE and Saudi Arabia have initiated R&D partnerships with Asian firms to develop specialty chemical zones that may include intermediates like Cyclopropanecarboxamide in the coming years.
Latin America
Latin America is currently not a major producer of Cyclopropanecarboxamide. However, Brazil has shown potential with several pharmaceutical and agrochemical companies expressing interest in localizing production to reduce import costs. Government incentives for chemical manufacturing in Brazil could lead to capacity building over the next five years.
Global Overview
Overall, Asia-Pacific accounts for over 70% of global Cyclopropanecarboxamide production in 2025. Europe contributes around 10%, North America about 7%, while the rest is split among Latin America and MEA. The trend is moving toward decentralization, with countries outside Asia investing in modular and cost-efficient production to secure domestic supply chains.
Cyclopropanecarboxamide Market Segmentation
Key Market Segments:
- By Application
- By End-Use Industry
- By Purity Grade
- By Geography
By Application
- Pharmaceutical Intermediates
- Agrochemical Intermediates
- Specialty Chemicals
- Research & Development
Pharmaceutical intermediates hold the largest share of the Cyclopropanecarboxamide market in 2025. The compound is used extensively in drug synthesis pathways and serves as a building block for active pharmaceutical ingredients (APIs). The demand for Cyclopropanecarboxamide in this segment is supported by the increasing need for advanced and targeted drug molecules.
Agrochemical intermediates represent the second-largest application segment. Cyclopropanecarboxamide is used in synthesizing crop protection chemicals such as herbicides and insecticides. Rising awareness about crop yield enhancement and pest resistance has bolstered the agrochemical industry’s need for this compound.
The specialty chemicals segment, though smaller, is steadily growing. It includes niche applications such as stabilizers, dyes, and industrial additives where Cyclopropanecarboxamide functions as a reactive intermediate.
R&D applications are vital, particularly in university laboratories, contract research organizations (CROs), and pilot plants. Though they account for a minor market share, they represent high-value transactions per unit volume.
By End-Use Industry
- Pharmaceuticals
- Agriculture
- Chemicals and Materials
- Academic and Research Institutions
The pharmaceutical industry dominates the Cyclopropanecarboxamide market due to the compound’s significant role in synthetic chemistry for drug development. This trend is reinforced by the rising number of clinical trials and the expansion of generic drug manufacturing globally.
Agriculture is another major end-use industry. The compound is employed in developing advanced agrochemicals to meet the needs of modern farming practices. Countries with large agrarian economies, like India and Brazil, show considerable uptake in this segment.
The chemicals and materials sector utilizes Cyclopropanecarboxamide as part of its intermediate product formulations. Although the consumption volume is moderate, the industry’s requirement for consistency and quality ensures stable demand.
Academic and research institutions represent a small but consistent demand source. These organizations use Cyclopropanecarboxamide for chemical synthesis training, innovation, and development of new molecules.
By Purity Grade
- Industrial Grade
- Pharmaceutical Grade
- Research Grade
Pharmaceutical-grade Cyclopropanecarboxamide is the most widely consumed grade due to its application in APIs and regulated environments. It is manufactured under strict quality control and regulatory frameworks.
Industrial-grade finds application in agrochemical and specialty chemical manufacturing. It is produced in bulk and usually doesn’t meet pharmaceutical-grade standards.
Research-grade Cyclopropanecarboxamide is produced in small volumes but is crucial for scientific investigations and product development. It commands a premium price due to its high purity levels and specific batch certifications.
By Geography
- Asia-Pacific
- North America
- Europe
- Latin America
- Middle East & Africa
Asia-Pacific is the largest consumer and producer, driven by strong demand from the Indian and Chinese pharmaceutical and agrochemical sectors. North America follows, largely as an importing region to serve its pharmaceutical R&D base. Europe maintains steady demand for high-purity material used in drug formulation. Latin America and MEA show growing interest but are currently at a developmental stage in terms of market size.